BNGO
Bionano Genomics Inc (BNGO)
Healthcare • NASDAQ • $1.29-3.01%
- Symbol
- BNGO
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $1.29
- Daily Change
- -3.01%
- Market Cap
- $14.31M
- Trailing P/E
- N/A
- Forward P/E
- -1.16
- 52W High
- $5.50
- 52W Low
- $1.06
- Analyst Target
- $5.00
- Dividend Yield
- N/A
- Beta
- 1.62
Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molecule imagers; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; B…
Company websiteResearch BNGO on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.